Abstract:Objective: With the modernization of traditional Chinese medicine (TCM) industry, the investment in research and development of new commercial Chinese polyherbal preparations (CCPPs) is increasing, and the varieties of CCPPs are growing. CCPPs play an increasingly important role in the TCM industry. This study has comprehensively summarized and analyzed the current situation of CCPPs that has been on the market in China, and provided suggestions for the research and promotion of CCPPs. Methods: This study took the CCPPs approved for marketing in domestic drug database of the National Medical Products Administration (NMPA) as the research object, and combined with the publication of related randomized controlled trials (RCTs) of CCPPs in 2020-2022 and the sales of CCPPs in domestic chain pharmacies, statistical analysis was carried out on the drug name, pharmaceutical companies, dosage form, number of flavors, CBDs, ICD-11 classification of diseases treated, etc. Results: Currently, 58,409 approvals for CCPPs have been issued in China, involving 9,986 varieties of CCPPs, 2,896 pharmaceutical companies and 39 dosage forms. The number of flavors of prescriptions of CCPPs varies from 1 to 90, among which Glycyrrhiza glabra L. [Fabaceae; Glycyrrhizae radix et rhizoma] and Angelica sinensis (Oliv.) Diels [Apiaceae; Angelicae sinensis radix] are the most widely used. The study found that the CCPPs with the most diverse variety is CCPPs for the treatment of respiratory diseases, some CCPPs can treat multiple system diseases. According to the survey, the sales of CCPPs for respiratory diseases in the chain pharmacies account for more than 1/3 of the total sales of the chain pharmacies, while the number of published randomized controlled trials (RCTs) on CCPPs for circulatory diseases was the largest. Conclusion: The approval process of CCPPs should be further standardized, and the transformation of TCM prescriptions into CCPPs should be promoted. In the approval process of CCPPs, it is suggested to strengthen the supervision of drug names to clarify the differences between the CCPPs of same name but different prescriptions. Improve the effectiveness and safety of CCPPs by improving the quality of CBDs. It is suggested to optimize the design of new drug research program of CCPPs to avoid waste of research resources.

[Traditional Chinese medicine preparations in medical institutions: current situation and inspirations on research and development of new traditional Chinese medicine preparations]

Database of traditional Chinese medicine and its application to studies of mechanism and to prescription validation.

[Research progress on clinically effective single preparations of traditional Chinese medicine]

[Evaluation for druggability of traditional Chinese medicine preparations in medical institutions based on human use experience]

[Category of Chinese medicine registration:historical evolution,current status,and problems].

A Development Opportunity and Strategic Thinking for the Comprehensive Healthcare Industry of Traditional Chinese Medicine

[Pharmaceutical changes and countermeasures for transformation of traditional Chinese medicine preparations in medical institutions into new drugs based on human use experience].

Development Strategy of Traditional Chinese Medicine in the New Era

[Current landscape and emerging trends in academic development of traditional Chinese medicine in new era]

[Traditional application and modern research progress on new foreign medicinal resources]

Research on Development of Modern Traditional Chinese Medicine in China

The development of traditional Chinese medicine

Status Quo and Development Strategy of Traditional Chinese Medicine in the New Era

Recent Progress of Research on Medicinal Mushrooms, Foods, and Other Herbal Products Used in Traditional Chinese Medicine

[Development of clinical trial of new drugs of traditional Chinese medicines]

Current Policies and Measures on the Development of Traditional Chinese Medicine in China

Chinese Medicine and Its Modernization Demands

TCM-based New Drug Discovery and Development in China

Overview of the quality standard research of traditional Chinese medicine

Commercial Chinese polyherbal preparation: current status and future perspectives

The key issues and development strategy of Chinese Classical Formulas pharmaceutical preparations